title: Diabetic macular edema.
authors.forename: Nicola G
authors.initials: NG
authors.lastname: Ghazi
authors.forename: Ryan T
authors.initials: RT
authors.lastname: Scruggs
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Batchelet
authors.forename: Michael W
authors.initials: MW
authors.lastname: Compton
authors.forename: Souha S
authors.initials: SS
authors.lastname: Allam
authors.forename: James
authors.initials: J
authors.lastname: Patrie
authors.forename: Haytham I
authors.initials: HI
authors.lastname: Salti
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D058449:Intravitreal Injections; D017075:Laser Coagulation; D008269:Macular Edema / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D041623:Tomography, Optical Coherence; D014222:Triamcinolone Acetonide / Q000627:therapeutic use; D014786:Vision Disorders / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide